Lung Disease and Pulmonary Hypertension
Lung disease can lead to the development of pulmonary hypertension, a condition characterized by abnormally elevated blood pressure in the lungs. There are various types of lung diseases that can contribute to the development of pulmonary arterial hypertension (PAH). Group 3 PAH, specifically caused by lung disease, includes conditions such as emphysema and pulmonary fibrosis.
In addition to emphysema and pulmonary fibrosis, other lung diseases that fall under this category are interstitial lung disease, sarcoidosis, histiocytosis X, cystic fibrosis, and pulmonary fibrosis. It is important to note that sleep disorders and sleep apnea can also contribute to lung problems and increase the risk of developing pulmonary arterial hypertension.
Chronic Thromboembolic Pulmonary Hypertension: The Dangers of Blood Clots
Blood clots pose a significant threat to blood flow within the body, causing various complications. When they occur in the arteries, they can directly contribute to heart failure. However, it is the presence of chronic blood clots in the lungs, known as pulmonary emboli in the medical field, that can lead to a condition called pulmonary arterial hypertension (PAH). Interestingly, even the remnants of previous blood clots can cause symptoms and further complications.
In the case of chronic thromboembolic pulmonary hypertension, these residual blood clot scars obstruct or severely narrow the pulmonary arteries, resulting in impaired blood flow and increased pressure. This condition is exceptionally perilous as the scar tissue becomes deformed and firmly attaches itself to the arterial wall lining. Consequently, it cannot be dislodged or ruptured to alleviate the blockage and restore proper blood flow.